82_FR_14069 82 FR 14019 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

82 FR 14019 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 50 (March 16, 2017)

Page Range14019-14020
FR Document2017-05193

Federal Register, Volume 82 Issue 50 (Thursday, March 16, 2017) 
[Federal Register Volume 82, Number 50 (Thursday, March 16, 2017)]
[Notices]
[Pages 14019-14020]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-05193]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.

[[Page 14020]]

    Date: April 10, 2017.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Brenda Lange-Gustafson, Ph.D., Scientific Review 
Officer, NIAID/NIH/DHHS, Scientific Review Program, 5601 Fishers 
Lane, Room 3G13, Rockville, MD 20852, 240-669-5047, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: March 10, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-05193 Filed 3-15-17; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 50 / Thursday, March 16, 2017 / Notices 14019 information about obligations and $10,000,000 for any period of time to:Vanietta Armstrong, Grants prohibitions under Federal civil rights during the period of performance of an Management Specialist, 5600 Fishers laws at http://www.hhs.gov/ocr/about- award/project. Lane, Mail Stop: 09E70, Rockville, MD us/contact-us/headquarters-and- 20857, Phone: (301) 443–4792, Fax: Mandatory Disclosure Requirements regional-addresses/index.html or call 1– (301) 594–0899, E-Mail: 800–368–1019 or TDD 1–800–537–7697. As required by 2 CFR part 200 of the Vanietta.Armstrong@ihs.gov. Also note it is an HHS Departmental Uniform Guidance, and the HHS 3. Questions on systems matters may goal to ensure access to quality, implementing regulations at 45 CFR part be directed to: Paul Gettys, Grant culturally competent care, including 75, effective January 1, 2016, the IHS Systems Coordinator, 5600 Fishers long-term services and supports, for must require a non-federal entity or an Lane, Mail Stop: 09E70, Rockville, MD vulnerable populations. For further applicant for a Federal award to 20857, Phone: (301) 443–2114; or the guidance on providing culturally and disclose, in a timely manner, in writing DGM main line (301) 443–5204, Fax: linguistically appropriate services, to the IHS or pass-through entity all (301) 594–0899, E-Mail: Paul.Gettys@ recipients should review the National violations of Federal criminal law ihs.gov. Standards for Culturally and involving fraud, bribery, or gratuity Linguistically Appropriate Services in violations potentially affecting the VIII. Other Information Health and Health Care at http:// Federal award. The Public Health Service strongly minorityhealth.hhs.gov/omh/ Submission is required for all encourages all cooperative agreement browse.aspx?lvl=2&lvlid=53. applicants and recipients, in writing, to and contract recipients to provide a Pursuant to 45 CFR 80.3(d), an the IHS and to the HHS Office of smoke-free workplace and promote the individual shall not be deemed Inspector General all information non-use of all tobacco products. In subjected to discrimination by reason of related to violations of Federal criminal addition, Pub. L. 103–227, the Pro- his/her exclusion from benefits limited law involving fraud, bribery, or gratuity Children Act of 1994, prohibits smoking by Federal law to individuals eligible violations potentially affecting the in certain facilities (or in some cases, for benefits and services from the IHS. Federal award. 45 CFR 75.113. any portion of the facility) in which Recipients will be required to sign the Disclosures must be sent in writing to: regular or routine education, library, HHS–690 Assurance of Compliance U.S. Department of Health and Human day care, health care, or early childhood form which can be obtained from the Services, Indian Health Service, development services are provided to following Web site: http://www.hhs.gov/ Division of Grants Management, children. This is consistent with the sites/default/files/forms/hhs-690.pdf, ATTN: Robert Tarwater, Director, HHS mission to protect and advance the and send it directly to the: U.S. 5600 Fishers Lane, Mail Stop: 09E70, physical and mental health of the Department of Health and Human Rockville, Maryland 20857, (Include American people. Services, Office of Civil Rights, 200 ‘‘Mandatory Grant Disclosures’’ in Dated: March 6, 2017. Independence Ave. SW., Washington, subject line), Ofc: (301) 443–5204, Chris Buchanan, DC 20201. Fax: (301) 594–0899, Email: Assistant Surgeon General, USPHS, Acting E. Federal Awardee Performance and Robert.Tarwater@ihs.gov. Director, Indian Health Service. Integrity Information System (FAPIIS) AND [FR Doc. 2017–05248 Filed 3–15–17; 8:45 am] The IHS is required to review and U.S. Department of Health and Human BILLING CODE 4165–16–P consider any information about the Services, Office of Inspector General, applicant that is in the Federal Awardee ATTN: Mandatory Grant Disclosures, Performance and Integrity Information Intake Coordinator, 330 Independence DEPARTMENT OF HEALTH AND System (FAPIIS) before making any Avenue SW., Cohen Building, Room HUMAN SERVICES award in excess of the simplified 5527, Washington, DC 20201, URL: acquisition threshold (currently http://oig.hhs.gov/fraud/report-fraud/ National Institutes of Health $150,000) over the period of index.asp, (Include ‘‘Mandatory Grant National Institute of Allergy and performance. An applicant may review Disclosures’’ in subject line), Fax: Infectious Diseases; Notice of Closed and comment on any information about (202) 205–0604 (Include ‘‘Mandatory Meeting itself that a Federal awarding agency Grant Disclosures’’ in subject line) or previously entered. IHS will consider Email: Pursuant to section 10(d) of the any comments by the applicant, in MandatoryGranteeDisclosures@ Federal Advisory Committee Act, as addition to other information in FAPIIS oig.hhs.gov. amended (5 U.S.C. App.), notice is in making a judgment about the Failure to make required disclosures hereby given of the following meeting. applicant’s integrity, business ethics, can result in any of the remedies The meeting will be closed to the and record of performance under described in 45 CFR 75.371 Remedies public in accordance with the Federal awards when completing the for noncompliance, including provisions set forth in sections review of risk posed by applicants as suspension or debarment (See 2 CFR 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., described in 45 CFR 75.205. parts 180 & 376 and 31 U.S.C. 3321). as amended. The grant applications and As required by 45 CFR part 75 the discussions could disclose Appendix XII of the Uniform Guidance, VII. Agency Contacts confidential trade secrets or commercial non-federal entities (NFEs) are required 1. Questions on the programmatic property such as patentable material, to disclose in FAPIIS any information issues may be directed to: Ms. Tina Tah, and personal information concerning mstockstill on DSK3G9T082PROD with NOTICES about criminal, civil, and administrative RN/BSN/MBA, Project Official/Indian individuals associated with the grant proceedings, and/or affirm that there is Health Service, 5600 Fishers Lane, applications, the disclosure of which no new information to provide. This Rockville, MD 20857, Phone: (301) 443– would constitute a clearly unwarranted applies to NFEs that receive Federal 0038, Fax: (301) 594–6213, E-Mail: invasion of personal privacy. awards (currently active grants, Tina.tah@ihs.gov. Name of Committee: National Institute of cooperative agreements, and 2. Questions on grants management Allergy and Infectious Diseases Special procurement contracts) greater than and fiscal matters may be directed Emphasis Panel; NIAID Peer Review Meeting. VerDate Sep<11>2014 17:12 Mar 15, 2017 Jkt 241001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\16MRN1.SGM 16MRN1

14020 Federal Register / Vol. 82, No. 50 / Thursday, March 16, 2017 / Notices Date: April 10, 2017. Time: 10:00 a.m. to 5:00 p.m. 16–023: Innovative Adaptations to Simplify Time: 10:00 a.m. to 2:00 p.m. Agenda: To review and evaluate contract Existing Technologies for Manipulation and Agenda: To review and evaluate grant proposals. Analysis of Glycans (U01). applications. Place: National Institutes of Health, 6701 Date: April 11, 2017. Place: National Institutes of Health, 5601 Rockledge Drive, Room 7182, Bethesda, MD Time: 10:00 a.m. to 6:00 p.m. Fishers Lane, Rockville, MD 20892 20892 (Virtual Meeting). Agenda: To review and evaluate grant (Telephone Conference Call). Contact Person: Susan Wohler Sunnarborg, applications. Contact Person: Brenda Lange-Gustafson, Ph.D., Scientific Review Officer, Office of Place: National Institutes of Health, 6701 Ph.D., Scientific Review Officer, NIAID/NIH/ Scientific Review/DERA, National, Heart, Rockledge Drive, Bethesda, MD 20892. DHHS, Scientific Review Program, 5601 Lung, and Blood Institute, 6701 Rockledge Contact Person: Vonda K Smith, Ph.D., Fishers Lane, Room 3G13, Rockville, MD Drive, Room 7182, Bethesda, MD 20892, 301– Scientific Review Officer, Center for 20852, 240–669–5047, bgustafson@ 827–7987, susan.sunnarborg@nih.gov. Scientific Review, National Institutes of niaid.nih.gov. (Catalogue of Federal Domestic Assistance Health, 6701 Rockledge Drive, Room 6188, (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for MSC 7892, Bethesda, MD 20892, 301–435– Program Nos. 93.855, Allergy, Immunology, Sleep Disorders Research; 93.837, Heart and 1789, smithvo@csr.nih.gov. and Transplantation Research; 93.856, Vascular Diseases Research; 93.838, Lung Name of Committee: Center for Scientific Microbiology and Infectious Diseases Diseases Research; 93.839, Blood Diseases Review Special Emphasis Panel; RFA CA16– Research, National Institutes of Health, HHS) and Resources Research, National Institutes 020: BD2K Support for Meetings. Dated: March 10, 2017. of Health, HHS Date: April 12, 2017. Dated: March 13, 2017. Time: 1:00 p.m. to 5:00 p.m. Natasha M. Copeland, Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory Anna Snouffer, applications. Committee Policy. Deputy Director, Office of Federal Advisory Place: National Institutes of Health, 6701 [FR Doc. 2017–05193 Filed 3–15–17; 8:45 am] Committee Policy. Rockledge Drive, Bethesda, MD 20892 BILLING CODE 4140–01–P [FR Doc. 2017–05280 Filed 3–15–17; 8:45 am] (Virtual Meeting). BILLING CODE 4140–01–P Contact Person: Craig Giroux, Ph.D., Scientific Review Officer, BST IRG, Center DEPARTMENT OF HEALTH AND for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5150, HUMAN SERVICES DEPARTMENT OF HEALTH AND Bethesda, MD 20892, 301–435–2204, HUMAN SERVICES girouxcn@csr.nih.gov. National Institutes of Health National Institutes of Health (Catalogue of Federal Domestic Assistance National Heart, Lung, and Blood Program Nos. 93.306, Comparative Medicine; Institute; Notice of Closed Meetings Center For Scientific Review; Notice of 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, Closed Meetings Pursuant to section 10(d) of the 93.846–93.878, 93.892, 93.893, National Federal Advisory Committee Act, as Pursuant to section 10(d) of the Institutes of Health, HHS) amended (5 U.S.C. App.), notice is Federal Advisory Committee Act, as Dated: March 13, 2017. hereby given of the following meetings. amended (5 U.S.C. App.), notice is Natasha M. Copeland, The meetings will be closed to the hereby given of the following meetings. Program Analyst, Office of Federal Advisory public in accordance with the The meetings will be closed to the Committee Policy. provisions set forth in sections public in accordance with the [FR Doc. 2017–05282 Filed 3–15–17; 8:45 am] 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., provisions set forth in sections BILLING CODE 4140–01–P as amended. The grant applications and 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., contract proposals and the discussions as amended. The grant applications and could disclose confidential trade secrets the discussions could disclose DEPARTMENT OF HEALTH AND or commercial property such as confidential trade secrets or commercial HUMAN SERVICES patentable material, and personal property such as patentable material, information concerning individuals and personal information concerning National Institutes of Health associated with the grant applications, individuals associated with the grant the disclosure of which would applications, the disclosure of which National Heart, Lung, and Blood constitute a clearly unwarranted would constitute a clearly unwarranted Institute; Notice of Closed Meeting invasion of personal privacy. invasion of personal privacy. Pursuant to section 10(d) of the Name of Committee: National Heart, Lung, Name of Committee: Center for Scientific Federal Advisory Committee Act, as and Blood Institute Special Emphasis Panel; Review Special Emphasis Panel; RFA–RM– amended (5 U.S.C. App.), notice is NHLBI Conference Grant Review (R13). 16–022: Novel and Innovative Tools to hereby given of the following meeting. Date: April 4, 2017. Facilitate Identification, Tracking, The meeting will be closed to the Time: 8:00 a.m. to 5:00 p.m. Manipulation, and Analysis of Glycans and Agenda: To review and evaluate grant their Functions (U01). public in accordance with the applications. Date: April 11, 2017. provisions set forth in sections Place: National Institutes of Health, 6701 Time: 10:00 a.m. to 6:00 p.m. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Rockledge Drive, Room 7184, Bethesda, MD Agenda: To review and evaluate grant as amended. The grant applications and 20892 (Virtual Meeting). applications. the discussions could disclose Contact Person: YingYing Li-Smerin, MD, Place: National Institutes of Health, 6701 confidential trade secrets or commercial Ph.D., Scientific Review Officer, Office of Rockledge Drive, Bethesda, MD 20892. property such as patentable material, mstockstill on DSK3G9T082PROD with NOTICES Scientific Review/DERA National Heart, Contact Person: Vonda K Smith, Ph.D., and personal information concerning Lung, and Blood Institute, 6701 Rockledge Scientific Review Officer, Center for individuals associated with the grant Drive, Room 7184, Bethesda, MD 20892– Scientific Review, National Institutes of 7924, 301–827–7942, lismerin@nhlbi.nih.gov. Health, 6701 Rockledge Drive, Room 6188, applications, the disclosure of which MSC 7892, Bethesda, MD 20892, 301–435– would constitute a clearly unwarranted Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; 1789, smithvo@csr.nih.gov. invasion of personal privacy. NHLBI Loan Repayment Program. Name of Committee: Center for Scientific Name of Committee: National Heart, Lung, Date: April 4, 2017. Review Special Emphasis Panel; RFA–RM– and Blood Institute Special Emphasis Panel; VerDate Sep<11>2014 17:12 Mar 15, 2017 Jkt 241001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\16MRN1.SGM 16MRN1


Document Created: 2017-03-16 02:19:00
Document Modified: 2017-03-16 02:19:00
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesApril 10, 2017.
FR Citation82 FR 14019 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR